Showing results (1-10 of 7) with videos related to
Sort By:
Pageof 1
Obesity (Silver Spring, Md.)|May 12, 2015
Earlier onset of diabesity-Induced adverse cardiac remodeling in female compared to male miceMarissa A Bowden, Greg H Tesch, Tracey L Julius, et al.Free Radical Biology & Medicine|March 5, 2013
Targeting the upregulation of reactive oxygen species subsequent to hyperglycemia prevents type 1 diabetic cardiomyopathy in miceKarina Huynh, Helen Kiriazis, Xiao-Jun Du, et al.Diabetes|March 11, 2010
Cardiac-specific IGF-1 receptor transgenic expression protects against cardiac fibrosis and diastolic dysfunction in a mouse model of diabetic cardiomyopathyKarina Huynh, Julie R McMullen, Tracey L Julius, et al.Plos One|November 13, 2012
The soluble guanylyl cyclase activator bay 58-2667 selectively limits cardiomyocyte hypertrophyJennifer C Irvine, Virat Ganthavee, Jane E Love, et al.American Journal of Physiology. Heart and Circulatory Physiology|June 5, 2013
HNO/cGMP-dependent antihypertrophic actions of isopropylamine-NONOate in neonatal rat cardiomyocytes: potential therapeutic advantages of HNO over NOJennifer C Irvine, Nga Cao, Swati Gossain, et al.British Journal of Pharmacology|August 29, 2012
Reperfusion-induced myocardial dysfunction is prevented by endogenous annexin-A1 and its N-terminal-derived peptide Ac-ANX-A1(2-26)Chengxue Qin, Keith D Buxton, Salvatore Pepe, et al.Plos One|April 17, 2012
Nitroxyl (HNO) stimulates soluble guanylyl cyclase to suppress cardiomyocyte hypertrophy and superoxide generationEliane Q Lin, Jennifer C Irvine, Anh H Cao, et al.Pageof 1